CRMMF News Alert CRH Medical Corp (CRMMF) 2.3400 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
CRH Medical Corp (CRMMF) 2.3400 $CRMMF

CRH Medical Announces Fiscal 2014 Results
CNW Group - Fri Feb 13, 8:41PM CST
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF) ("CRH" or the "Company" , a North American medical company focused on providing physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced its audited financial results for the year ended December 31, 2014. These results reflect the full year of existing operations derived from the CRH O'Regan System and one month of financial results from the anesthesia services business CRH acquired in December 2014. All financial results are expressed in U.S. dollars.
CRH.TO: 2.91 (+0.10)

Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Disposition of Common Shares in the Capital of CRH Medical Corporation
Marketwired - Fri Dec 05, 9:35AM CST
Fernbank LLC ("Fernbank" announces that it is in the process of winding down. As part of this winding down, Fernbank has made an in-kind distribution of many of the common shares of CRH Medical Corporation ("CRH" previously held by Fernbank to the members of Fernbank. Fernbank continues to own some common shares of CRH, but it is less than 10% of the issued and outstanding shares of CRH.

IIROC Trade Resumption - CRH
CNW Group - Tue Dec 02, 9:45AM CST
Trading resumes in:

IIROC Trade Resumption - CRH Medical Corporation
Newsfile Corp - Tue Dec 02, 9:33AM CST
Trading resumes in:

Knight Therapeutics Inc. and CRH Medical Corporation Sign Secured Debt Financing Agreement
Marketwired - Tue Dec 02, 9:15AM CST
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into a senior secured debt agreement with CRH Medical Corporation (TSX: CRH)(OTCQX: CRMMF) ("CRH" , a North American medical company focused on providing physicians with innovative products and services for the treatment of gastrointestinal diseases. This secured loan will fund CRH's acquisition of Gastroenterology Anesthesia Associates, LLC and GAA Management, LCC, collectively a Southeast US-based Anesthesia services provider ("GAA" .
CRH.TO: 2.91 (+0.10), GUD.TO: 8.70 (-0.05)

CRH Medical Announces Significant Acquisition
CNW Group - Tue Dec 02, 9:15AM CST
Transaction marks significant expansion of CRH's gastrointestinal business
CRH.TO: 2.91 (+0.10)

IIROC Trade Halt - CRH Medical Corporation
Newsfile Corp - Tue Dec 02, 7:48AM CST
The following issues have been halted by IIROC:

CRH Medical Announces Third Quarter 2014 Results
CNW Group - Mon Oct 27, 4:00PM CDT
- Company Reports Record Quarterly Revenue of $2.2 Million -
CRH.TO: 2.91 (+0.10)

CRH Medical Announces Release Date for Third Quarter 2014 Results and Conference Call
CNW Group - Wed Oct 15, 12:00PM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced that it plans to release its financial results for the third quarter ended September 30, 2014, after market close on Monday, October 27, 2014.
CRH.TO: 2.91 (+0.10)

CRH Medical Announces Second Quarter 2014 Results
CNW Group - Wed Jul 30, 4:00PM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced its unaudited financial results for its second quarter, ended June 30, 2014. All financial results are expressed in U.S dollars.
CRH.TO: 2.91 (+0.10)

CRH Medical Announces Voting Results of Shareholders Meeting
CNW Group - Fri Jun 20, 6:00AM CDT
CRH Medical Corporation (the "Company" (TSX: CRH) (OTCQX: CRMMF), announces the following voting results for the Company's 2014 Annual Meeting of Shareholders (the "Meeting" . At the Meeting, the nominees listed in the Company's management proxy circular were re-elected as directors, KPMG LLP was appointed as auditor of the Company for the coming year and certain other resolutions were passed as discussed below.
CRH.TO: 2.91 (+0.10)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing

Updated Category News Views 308

Ameripath USA's New Partnership for Recovery Housing Ameripath USA has formed a strategic partnership with Recovery Resolutions LLC to significantly improve access to high-quality Addiction Recovery Homes throughout the country. This collaboration merges Ameripath's extensive real estate expertise with Recovery Resolutions' impressive success model, boasting a 95% success...

Continue Reading
Finzly’s ISO 20022 Migration Readiness Sets Industry Standards

Updated Category News Views 311

Finzly’s Innovations in ISO 20022 Payment Standards Finzly is at the forefront of transforming how financial institutions manage payments through its state-of-the-art platform designed for modern banking needs. As the shift to SWIFT MX ISO 20022 continues, Finzly's clientele is emerging as early adopters, demonstrating a commitment to embracing new technologies that...

Continue Reading
Innovative Drug Delivery Solutions for Parkinson's Disease

Updated Category News Views 251

Serina Therapeutics' Approach to Parkinson's Disease Serina Therapeutics is at the forefront of developing new treatments for complex neurological disorders, particularly Parkinson’s disease. This progressive neurological disorder significantly impacts motor functions and quality of life for those affected. With innovative solutions on the horizon, Serina is prepared to...

Continue Reading
Waters Corporation Leader to Speak at HealthCONx Conference

Updated Category News Views 124

Waters Corporation to Participate in HealthCONx Conference Waters Corporation (NYSE: WAT), located in Milford, Massachusetts, is pleased to announce its participation in the upcoming HealthCONx Conference. Udit Batra, the President and Chief Executive Officer of Waters, will engage in an insightful fireside chat set for Wednesday, December 4th, 2024, at 10:00 AM Eastern...

Continue Reading
mRNA Synthesis and Manufacturing Market Expected to Grow Steadily

Updated Category News Views 33

Growing Insights into the mRNA Synthesis and Manufacturing Market The mRNA synthesis and manufacturing market is on a promising trajectory, with projections indicating substantial growth from USD 624.4 million to USD 738.3 million by 2029. This expansion translates into a compound annual growth rate (CAGR) of 3.4%. Several factors are propelling this growth, including an...

Continue Reading